128 studies found for:    Open Studies | "Neuroblastoma"
Show Display Options
Rank Status Study
21 Recruiting Anti-angiogenetic Therapy With Radiotherapy for Pediatric Neuroblastoma
Condition: Neuroblastoma
Interventions: Drug: Endostar;   Radiation: 21.6Gy/12Fx to the tumor bed and 36Gy/20Fx to the tumor
22 Recruiting A Combined Cell Therapy Approach to the Treatment of Neuroblastoma
Conditions: Neuroblastoma;   Neoplasms, Nerve Tissue
Interventions: Procedure: Autologous Hematopoietic Progenitor Cell Transplant;   Biological: KLH and Tumor Lysate Pulsed DC Vaccine
23 Unknown  Nurse Case Manager Model on Neuroblastoma Caregiver's Uncertainty
Condition: Neuroblastoma
Intervention:
24 Recruiting 4SCAR-GD2 Targeting Refractory and/or Recurrent Neuroblastoma
Conditions: Neuroblastoma;   Effects of Immunotherapy
Intervention: Genetic: 4SCAR-GD2
25 Recruiting Anti-GD2 3F8 Antibody and Allogeneic Natural Killer Cells for High-Risk Neuroblastoma
Conditions: Neuroblastoma;   Bone Marrow, Sympathetic Nervous System
Intervention: Drug: cyclophosphamide, vincristine, topotecan ,allogeneic NK cells & 3F8
26 Not yet recruiting Immunotherapy of Relapsed Refractory Neuroblastoma With Expanded NK Cells
Condition: Neuroblastoma
Interventions: Drug: Ch14.18;   Biological: NK Cells;   Drug: Lenalidomide
27 Recruiting Sorafenib and Cyclophosphamide/Topotecan in Patients With Relapsed and Refractory Neuroblastoma
Condition: Neuroblastoma
Interventions: Drug: Sorafenib;   Drug: Cyclophosphamide;   Drug: Topotecan
28 Recruiting A Pilot Study of Activated T Cell Therapy for Refractory/Relapsed Neuroblastoma
Condition: Neuroblastoma
Intervention: Biological: Activated T lymphocyte
29 Recruiting 124I-Metaiodobenzylguanidine (MIBG) PET/CT Diagnostic Imaging and Dosimetry for Patients With Neuroblastoma: A Pilot Study
Condition: Neuroblastoma
Interventions: Radiation: 124I-MIBG (no-carrier added);   Radiation: 124I-MIBG (carrier added)
30 Recruiting Phase II Study of Monoclonal Antibody ch14.18/CHO Continuous Infusion in Patients With Primary Refractory or Relapsed Neuroblastoma
Condition: Neuroblastoma
Intervention: Drug: dinutuximab beta
31 Not yet recruiting Safety Study of Dinutuximab Combined With Immunotherapy to Treat Neuroblastoma
Conditions: Neuroblastoma;   Neoplasm, Residual;   Effects of Immunotherapy
Intervention: Drug: Dinutuximab. Immunotherapy
32 Recruiting MIBG for Refractory Neuroblastoma and Pheochromocytoma
Conditions: Relapsed Neuroblastoma;   Metastatic Pheochromocytoma
Interventions: Drug: 131 I-Metaiodobenzylguanidine (131I-MIBG);   Drug: Potassium iodide solution;   Drug: G-CSF;   Procedure: hematopoietic stem cell infusion
33 Not yet recruiting 3RD GENERATION GD2 SPECIFIC CHIMERIC ANTIGEN RECEPTOR TRANSDUCED AUTOLOGOUS NATURAL KILLER T-CELLS FOR NEUROBLASTOMA
Condition: Neuroblastoma
Interventions: Drug: cyclophosphamide;   Drug: Fludarabine;   Genetic: GINAKIT Cells
34 Recruiting Monitor Response to Treatment in Neuroblastoma Using 3&Apos;-Deoxy-3&Apos;-Fluorothymidine- Positron Emission Tomography (FLT-PET)
Condition: Neuroblastoma
Intervention: Device: FLT-PET
35 Unknown  131I-MIBG With Myeloablative Chemotherapy and Autologous Stem Cell Transplantation for the Treatment of High-risk Neuroblastoma
Condition: Neuroblastoma
Intervention: Drug: 131I-MIBG , Etoposide, Melphalan, Carboplatin, Autologous Peripheral Stem Cell Transplantation
36 Recruiting Parental Decision-Making for Children With Relapsed Neuroblastoma
Condition: Relapsed Neuroblastoma
Intervention:
37 Unknown  Haplo-identical Hematopoietic Stem Cell Transplantation Following Reduced-intensity Conditioning in Children With Neuroblastoma
Condition: Neuroblastoma
Intervention: Drug: Busulfan - Fludarabine - TBI
38 Recruiting Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
Conditions: Neuroblastoma;   Pheochromocytoma
Intervention: Radiation: iobenguane I 131
39 Recruiting Multimodal Molecular Targeted Therapy to Treat Relapsed or Refractory High-risk Neuroblastoma
Condition: Neuroblastoma Recurrent
Interventions: Drug: Dasatinib;   Drug: Rapamycin;   Drug: Irinotecan;   Drug: Temozolomide
40 Not yet recruiting Metronomic Treatment in Children and Adolescents With Recurrent or Progressive High Risk Neuroblastoma
Condition: Neuroblastoma Recurrent
Intervention: Drug: metronomic therapy

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years